About Zuellig Pharma
Zuellig Pharma is a company based in Singapore (Singapore) founded in 1992. It operates as a B2B2C and Managed Services. Zuellig Pharma has completed 4 acquisitions, including Alliance Pharma Cambodge, Klinify and MiCare. Zuellig Pharma offers products and services including eZRx+, Clinical Trial Support, and Patient Care Solutions. Zuellig Pharma operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Fabtech and Science Group, among others.
- Headquarter Singapore, Singapore
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zuellig Pharma Holdings
- Date of Incorporation 02 Mar, 2015
- Jurisdiction Bhiwandi, Maharashtra, India
-
Annual Revenue
$610.02 K (USD)-31.96as on Mar 31, 2022
-
Net Profit
$66.94 K (USD)-25.45as on Mar 31, 2022
-
EBITDA
$87.6 K (USD)-39.61as on Mar 31, 2022
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Alliance Pharma Cambodge
& 3 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Zuellig Pharma
Zuellig Pharma offers a comprehensive portfolio of products and services, including eZRx+, Clinical Trial Support, and Patient Care Solutions.
B2B healthcare platform launched for efficient distribution solutions.
Support for clinical trials with advanced logistics infrastructure.
Digital solutions prioritizing patient safety and healthcare management.
People of Zuellig Pharma
Unlock access to complete
Funding Insights of Zuellig Pharma
Investors in Zuellig Pharma
Zuellig Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Temasek.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
An investment platform is provided for diverse sectors and geographies.
|
Locked | Locked | Locked |
Investor details for Zuellig Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zuellig Pharma
Zuellig Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Alliance Pharma Cambodge, Klinify and MiCare.
Investment portfolio details for Zuellig Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Patient records are managed through a cloud-based platform for clinics.
|
Locked | Locked | 2011 | Locked | |
|
Third-party administration services are provided in Malaysia.
|
Locked | Locked | 2006 | Locked | |
|
Pharmaceutical products are distributed and stored in Cambodia.
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for Zuellig Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Zuellig Pharma
Detailed financials for Zuellig Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zuellig Pharma Comparisons
Peer comparison for Zuellig Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zuellig Pharma
Zuellig Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Fabtech and Science Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Instruments for biotech, pharmaceutical, and biomedical sectors are manufactured.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
Detailed competitors of Zuellig Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zuellig Pharma
Complete news archive for Zuellig Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zuellig Pharma
Zuellig Pharma was founded in 1992 and raised its 1st funding round 15 years after it was founded.
Zuellig Pharma is headquartered in Singapore, Singapore.
John Graham is the current CEO of Zuellig Pharma.
Annual revenue of Zuellig Pharma is $610.02K as on Mar 31, 2022.
Healthcare access across Asia is facilitated by Zuellig Pharma through integrated solutions. The company operates in pharmaceuticals, medical devices, consumer healthcare, vaccines, animal health, and specialty care. Innovative distribution, commercialization, clinical trial support, and patient care solutions are provided. Partnerships with manufacturers, governments, and healthcare providers are leveraged to expand reach. State-of-the-art technology and logistics, including cold chain solutions, are utilized to bridge healthcare gaps in 13 markets.
Zuellig Pharma's top competitors include Indegene, IntegriChain and Clinigen.
Zuellig Pharma offers eZRx+, Clinical Trial Support, and Patient Care Solutions.
Zuellig Pharma has made 4 acquisitions, including Alliance Pharma Cambodge, Klinify, and MiCare.
Zuellig Pharma has 1 investor. Key investors include Temasek.